211 related articles for article (PubMed ID: 1691053)
1. Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
Gerbracht U; Bursch W; Kraus P; Putz B; Reinacher M; Timmermann-Trosiener I; Schulte-Hermann R
Carcinogenesis; 1990 Apr; 11(4):617-24. PubMed ID: 1691053
[TBL] [Abstract][Full Text] [Related]
2. Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver.
Kraupp-Grasl B; Huber W; Putz B; Gerbracht U; Schulte-Hermann R
Cancer Res; 1990 Jun; 50(12):3701-8. PubMed ID: 1971196
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital.
Grasl-Kraupp B; Waldhör T; Huber W; Schulte-Hermann R
Carcinogenesis; 1993 Nov; 14(11):2407-12. PubMed ID: 8242872
[TBL] [Abstract][Full Text] [Related]
4. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously.
Kraupp-Grasl B; Huber W; Taper H; Schulte-Hermann R
Cancer Res; 1991 Jan; 51(2):666-71. PubMed ID: 1985784
[TBL] [Abstract][Full Text] [Related]
5. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
[TBL] [Abstract][Full Text] [Related]
6. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters.
Bursch W; Lauer B; Timmermann-Trosiener I; Barthel G; Schuppler J; Schulte-Hermann R
Carcinogenesis; 1984 Apr; 5(4):453-8. PubMed ID: 6231134
[TBL] [Abstract][Full Text] [Related]
7. Effects of non-genotoxic hepatocarcinogens phenobarbital and nafenopin on phenotype and growth of different populations of altered foci in rat liver.
Schulte-Hermann R; Kraupp-Grasl B; Bursch W; Gerbracht U; Timmermann-Trosiener I
Toxicol Pathol; 1989; 17(4 Pt 1):642-9; discussion 649-50. PubMed ID: 2576472
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis.
Préat V; Lans M; de Gerlache J; Taper H; Roberfroid M
Jpn J Cancer Res; 1986 Jul; 77(7):629-38. PubMed ID: 2875050
[TBL] [Abstract][Full Text] [Related]
9. Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis.
Numoto S; Furukawa K; Furuya K; Williams GM
Carcinogenesis; 1984 Dec; 5(12):1603-11. PubMed ID: 6149819
[TBL] [Abstract][Full Text] [Related]
10. Dose-response studies on the effects of alpha-, beta-, and gamma-hexachlorocyclohexane on putative preneoplastic foci, monooxygenases, and growth in rat liver.
Schröter C; Parzefall W; Schröter H; Schulte-Hermann R
Cancer Res; 1987 Jan; 47(1):80-8. PubMed ID: 2431769
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic alteration of hepatocellular foci in rats treated with clofibrate and phenobarbital.
Hasegawa R; Yoshida T; Mizoguchi Y; Futakuchi M; Kim DJ; Cui L; Ito N
Cancer Lett; 1994 Aug; 83(1-2):89-95. PubMed ID: 8062238
[TBL] [Abstract][Full Text] [Related]
12. Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility.
Greaves P; Irisarri E; Monro AM
J Natl Cancer Inst; 1986 Mar; 76(3):475-84. PubMed ID: 2869179
[TBL] [Abstract][Full Text] [Related]
13. The role of growth of normal and preneoplastic cell populations for tumor promotion in rat liver.
Schulte-Hermann R; Schuppler J; Timmermann-Trosiener I; Ohde G; Bursch W; Berger H
Environ Health Perspect; 1983 Apr; 50():185-94. PubMed ID: 6873013
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of peroxisomal enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin.
Grasl-Kraupp B; Huber W; Just W; Gibson G; Schulte-Hermann R
Carcinogenesis; 1993 May; 14(5):1007-12. PubMed ID: 8099311
[TBL] [Abstract][Full Text] [Related]
15. Effect of hypolipidemic drugs, nafenopin and clofibrate, on the concentration of ligandin and Z protein in rat liver.
Fleischner G; Meijer DK; Levine WG; Gatmaitan Z; Gluck R; Arias IM
Biochem Biophys Res Commun; 1975 Dec; 67(4):1401-7. PubMed ID: 812503
[No Abstract] [Full Text] [Related]
16. Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate.
Bursch W; Düsterberg B; Schulte-Hermann R
Arch Toxicol; 1986 Dec; 59(4):221-7. PubMed ID: 2435263
[TBL] [Abstract][Full Text] [Related]
17. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers.
Xu YH; Campbell HA; Sattler GL; Hendrich S; Maronpot R; Sato K; Pitot HC
Cancer Res; 1990 Feb; 50(3):472-9. PubMed ID: 1967547
[TBL] [Abstract][Full Text] [Related]
18. Effect of rat developmental stage at initiation on the expression of biochemical markers during liver tumor promotion.
Decloître F; Lafarge-Frayssinet C; Barroso M; Lechner MC; Ouldelhkim M; Frayssinet C
Tumour Biol; 1990; 11(6):295-305. PubMed ID: 1700861
[TBL] [Abstract][Full Text] [Related]
19. Facilitated expression of adaptive responses to phenobarbital in putative pre-stages of liver cancer.
Schulte-Hermann R; Timmermann-Trosiener I; Schuppler J
Carcinogenesis; 1986 Oct; 7(10):1651-5. PubMed ID: 2875809
[TBL] [Abstract][Full Text] [Related]
20. The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital.
Goldsworthy TL; Pitot HC
Carcinogenesis; 1985 Sep; 6(9):1261-9. PubMed ID: 2863007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
